Exact Mass: 354.18647000000004
Exact Mass Matches: 354.18647000000004
Found 374 metabolites which its exact mass value is equals to given mass value 354.18647000000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Vincamine
C21H26N2O3 (354.19433260000005)
Vincamine is a vinca alkaloid, an alkaloid ester, an organic heteropentacyclic compound, a methyl ester and a hemiaminal. It has a role as an antihypertensive agent, a vasodilator agent and a metabolite. It is functionally related to an eburnamenine. Vincamine is a monoterpenoid indole alkaloid obtained from the leaves of *Vinca minor* with a vasodilatory property. Studies indicate that vincamine increases the regional cerebral blood flow. Vincamine is a natural product found in Vinca difformis, Vinca major, and other organisms with data available. A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders. Vincamine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1617-90-9 (retrieved 2024-07-01) (CAS RN: 1617-90-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2]. Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2].
Yohimbine
C21H26N2O3 (354.19433260000005)
Yohimbine is an indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina. It has a role as an alpha-adrenergic antagonist, a serotonergic antagonist and a dopamine receptor D2 antagonist. It is functionally related to a yohimbic acid. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. Yohimbine is an indole alkaloid derived from the bark of the Central African yohimbe tree (Pausinystalia yohimbe) that is widely used as therapy for erectile dysfunction. Yohimbine use has been associated with occasional severe adverse events, but has not been linked to serum enzyme elevations or clinically apparent acute liver injury. Yohimbine is a natural product found in Rauvolfia yunnanensis, Tabernaemontana corymbosa, and other organisms with data available. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine Hydrochloride (active moiety of) ... View More ... Yohimbine is only found in individuals that have used or taken this drug. It is a plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. [PubChem]Yohimbine is a pre-synaptic alpha 2-adrenergic blocking agent. The exact mechanism for its use in impotence has not been fully elucidated. However, yohimbine may exert its beneficial effect on erectile ability through blockade of central alpha 2-adrenergic receptors producing an increase in sympathetic drive secondary to an increase in norepinephrine release and in firing rate of cells in the brain noradrenergic nuclei. Yohimbine-mediated norepinephrine release at the level of the corporeal tissues may also be involved. In addition, beneficial effects may involve other neurotransmitters such as dopamine and serotonin and cholinergic receptors. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction An indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents D001697 - Biomedical and Dental Materials > D003764 - Dental Materials Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]
Tephrowatsin A
A hydroxyflavan that is (2S)-flavan substituted by hydroxy group at position 4, methoxy groups at positions 5 and 7 and a prenyl group at position 8 respectively.
17-O-acetylnorajmaline
C21H26N2O3 (354.19433260000005)
An indole alkaloid obtained by formal acetylation of the 17-hydroxy group of norajmaline.
3,6-Dimethoxyestra-1,3,5(10),6,8-pentaene-17beta-carboxylic acid methyl ester
N-demethylvindolidine
C21H26N2O3 (354.19433260000005)
Corynanthin
C21H26N2O3 (354.19433260000005)
Methyl 17-hydroxy-20xi-yohimban-16-carboxylate is a yohimban alkaloid, a methyl ester and an organic heteropentacyclic compound. Methyl 17-hydroxy-20xi-yohimban-16-carboxylate is a natural product found in Aspidosperma oblongum, Aspidosperma ramiflorum, and other organisms with data available. D001697 - Biomedical and Dental Materials > D003764 - Dental Materials
Acetylsalvipisone
Acetylsalvipisone is found in alcoholic beverages. Acetylsalvipisone is a constituent of Salvia sclarea (clary sage)
1-dodecanoyl-glycero-3-phosphate
1-dodecanoyl-glycero-3-phosphate is also known as LPA(12:0/0:0) or (2R)-2-Hydroxy-3-(phosphonooxy)propyl laurate. 1-dodecanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-dodecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(i-12:0/0:0)
LysoPA(i-12:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-12:0/0:0), in particular, consists of one chain of isododecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Corynanthine
C21H26N2O3 (354.19433260000005)
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
Hydroxybenzylpindolol
C21H26N2O3 (354.19433260000005)
Isovincamine
C21H26N2O3 (354.19433260000005)
Bronica
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents R - Respiratory system > R03 - Drugs for obstructive airway diseases D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].
7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid
17-O-acetylnorajmaline
C21H26N2O3 (354.19433260000005)
17-o-acetylnorajmaline is a member of the class of compounds known as ajmaline-sarpagine alkaloids. Ajmaline-sarpagine alkaloids are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. 17-o-acetylnorajmaline is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 17-o-acetylnorajmaline can be found in a number of food items such as black chokeberry, sapodilla, common pea, and cardamom, which makes 17-o-acetylnorajmaline a potential biomarker for the consumption of these food products.
(1R,2S,4S,7Z,8R,9S)-7-ethylidene-1-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.0^{4,9]dodecane-2,3-indole]-2-one
C21H26N2O3 (354.19433260000005)
Dregamine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several species of Tabernaemontana.
Sitsirikine
C21H26N2O3 (354.19433260000005)
methyl (2R)-2-[(2S,3R,12bS)-3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate is a natural product found in Alstonia angustifolia, Rauvolfia caffra, and Strychnos pungens with data available.
10-Hydroxycoronaridine
C21H26N2O3 (354.19433260000005)
An organic heteropentacyclic compound that is coronaridine in which the hydrogen of the indole moiety that is para- to the indole nitrogen has been replaced by a hydroxy group.
10-methoxy-2,7-dihydropleiocarpamine
C21H26N2O3 (354.19433260000005)
(+/-)-N-formyltortuosamine|N-Formyl-(??)-(??)-Tortuosamine|N-Formyltortuosamin|N-formyltortuosamine|N-{2-[6-(3,4-dimethoxy-phenyl)-5,6,7,8-tetrahydro-quinolin-6-yl]-ethyl}-N-methyl-formamide
C21H26N2O3 (354.19433260000005)
(+/-)-19-hydroxycoronaridine|(-)-19S-heynanine
C21H26N2O3 (354.19433260000005)
16-hydroxymethyl-4,5-seco-condyfol-14(19)-ene-16-carboxylic acid methyl ester|Precondylocarpin
C21H26N2O3 (354.19433260000005)
Corynanthine
C21H26N2O3 (354.19433260000005)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.574 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.571 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.566 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.567
Ibogamine-18-carboxylicacid, 13-hydroxy-, methyl ester (9CI)
C21H26N2O3 (354.19433260000005)
tabernaemontanine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several species of Tabernaemontana.
17-hydroxy-19,20-dihydro-sarpagane-16-carboxylic acid methyl ester|19, 20-Dihydropolyneuridine|Dihydroakuammidin
C21H26N2O3 (354.19433260000005)
(ent-5alpha,15()-16-Chloro-3,15-dihydroxy-3-erythroxylen-2-one
(15S)-hydroxy-14,15-dihydrovindolinine
C21H26N2O3 (354.19433260000005)
(17alpha)-17-hydroxykopsinine|(2alpha,3beta,4alpha,5alpha,12R,19alpha)-4-hydroxy-2,21-cycloaspidospermidine-3-carboxylic acid|17alpha-hydroxykopsinine|kopsiloscine G
C21H26N2O3 (354.19433260000005)
3,5-Ethano-3H-pyrrolo[2,3-d]carbazole-6-carboxylic acid, 4-ethyl-1,2,3a,4,5,7-hexahydro-11-methoxy-, methyl ester, stereoisomer
C21H26N2O3 (354.19433260000005)
1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H-beta-carbolin-1-yl)cyclopentanol
C21H26N2O3 (354.19433260000005)
17-hydroxy-14,15-dihydrotabersonine
C21H26N2O3 (354.19433260000005)
11,12-dimethoxy-14,15-dihydro-eburnamenin-14-one|Dimethoxy-eburnamonin|Dimethoxyeburnamonine
C21H26N2O3 (354.19433260000005)
(+-)-Vincamin|14-hydroxy-14,15-dihydro-eburnamenine-14-carboxylic acid methyl ester|Vinkamin
C21H26N2O3 (354.19433260000005)
flabelliformine|methyl (3E,4S)-3-ethylidene-4-{1-[3-(methoxymethyl)-1H-indol-2-yl]ethenyl}piperidine-1-carboxylate
C21H26N2O3 (354.19433260000005)
ent-5alpha,16-chloro-2-oxodolabr-3-ene-3,15xi-diol
20-Epiervatamin|4-ethyl-2-methyl-6-oxo-2,3,4,4a,5,6,7,12-octahydro-1H-pyrido[3,4:4,5]cyclohepta[1,2-b]indole-12a-carboxylic acid methyl ester
C21H26N2O3 (354.19433260000005)
(19S)-1-acetyl-17,19-epoxy-curan-3-ol|Acetylisostrychnosplendine|N(a)-Acetyl-isostrychnosplendin|N-acetyl-isostrychnosplendine
C21H26N2O3 (354.19433260000005)
12-hydroxy-21,22-dihydro-12,24-seco-strychnidin-10-one|Protostrychnin|Protostrychnine
C21H26N2O3 (354.19433260000005)
Aspidoalbidine, 1-formyl-17-methoxy-
C21H26N2O3 (354.19433260000005)
Rauwolscine
C21H26N2O3 (354.19433260000005)
Rauwolscine is a methyl 17-hydroxy-20xi-yohimban-16-carboxylate. Rauwolscine is a natural product found in Alstonia constricta, Corynanthe johimbe, and other organisms with data available. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.455 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.448 Rauwolscine is a selective α2-adrenoceptor antagonist that inhibits tumor growth and induces apoptosis[1].
Alloyohimbin
C21H26N2O3 (354.19433260000005)
Allo-yohimbine is a methyl 17-hydroxy-20xi-yohimban-16-carboxylate. allo-Yohimbine is a natural product found in Corynanthe johimbe, Alstonia yunnanensis, and other organisms with data available.
Humantenine
C21H26N2O3 (354.19433260000005)
Annotation level-1 Humantenine is a natural product found in Gelsemium elegans and Gelsemium rankinii with data available.
Yohimbine
C21H26N2O3 (354.19433260000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2282 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.556 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.553 Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]
methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
C21H26N2O3 (354.19433260000005)
C21H26N2O3_Methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate
C21H26N2O3 (354.19433260000005)
Alloyohimbine
C21H26N2O3 (354.19433260000005)
Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Yohimbinoid alkaloids, Indole alkaloids
Vincamin
C21H26N2O3 (354.19433260000005)
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2327 Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2]. Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2].
2,2,4-Trimethylpentane-1,3-diyl dibenzoate
CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10463; ORIGINAL_PRECURSOR_SCAN_NO 10461 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10565; ORIGINAL_PRECURSOR_SCAN_NO 10560 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10586; ORIGINAL_PRECURSOR_SCAN_NO 10581
Ala Ala Pro Pro
C16H26N4O5 (354.19031060000003)
Ala Pro Ala Pro
C16H26N4O5 (354.19031060000003)
Ala Pro Pro Ala
C16H26N4O5 (354.19031060000003)
Pro Ala Ala Pro
C16H26N4O5 (354.19031060000003)
Pro Ala Pro Ala
C16H26N4O5 (354.19031060000003)
Pro Pro Ala Ala
C16H26N4O5 (354.19031060000003)
Rauhimbin
C21H26N2O3 (354.19433260000005)
Acetylsalvipisone
6-[3-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-1-yl]-2-fluoropyridine-3-carboxylic acid
C17H27FN2O3Si (354.17748839999996)
(2S,3S)-[2-(3-HYDROXYPYRROLIDIN-1-YL)-1-PHENYLETHYL]METHYLCARBAMICACIDBENZYLESTER
C21H26N2O3 (354.19433260000005)
N-(hydroxymethyl)prop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enenitrile
(Triphenylen-2-yl)boronic acid pinacol ester
C24H23BO2 (354.17910079999996)
Piperazine-1-carboxamidine hemisulfate
C10H26N8O4S (354.17976360000006)
3,7-Dioxa-4,6-disilanonane, 4,4,6,6-tetraethoxy-5-methyl-
4,4-bis-(2,3-Epoxypropoxy)-3,3,5,5-tetramethylbiphenyl
1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid
Piperazine-1-carboxamidine 0.5-sulfate
C10H26N8O4S (354.17976360000006)
Zicronapine
C22H27ClN2 (354.18626520000004)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1. VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.
vinca
C21H26N2O3 (354.19433260000005)
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
4-(2-((2-Hydroxy-3-(1H-indol-4-yloxy)propyl)amino)-2-methylpropyl)phenol
C21H26N2O3 (354.19433260000005)
4-(9H-fluoren-9-yl)-N-(4-pyridinylmethylene)-1-piperazinamine
7-Amino-2-Tert-Butyl-4-{[2-(1h-Imidazol-4-Yl)ethyl]amino}pyrido[2,3-D]pyrimidine-6-Carboxamide
Seratrodast
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents R - Respiratory system > R03 - Drugs for obstructive airway diseases D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].
Corynine
C21H26N2O3 (354.19433260000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]
Stemmadenin
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several plant species including Rhazya stricta, Tabernaemontana dichotoma and Aspidosperma pyricollum.
methyl (2R)-2-[(2R,3Z,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
[3-carboxy-2-[(2E,5E,7E)-10-carboxydeca-2,5,7-trienoyl]oxypropyl]-trimethylazanium
C18H28NO6+ (354.19165280000004)
[3-carboxy-2-[(4E,6E,8E)-10-carboxydeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium
C18H28NO6+ (354.19165280000004)
[3-carboxy-2-[(5E,7E,9E)-10-carboxydeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium
C18H28NO6+ (354.19165280000004)
[3-carboxy-2-[(3E,6E,9E)-10-carboxydeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium
C18H28NO6+ (354.19165280000004)
7-Benzyl-1,3-dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2,6-dione
C18H22N6O2 (354.18041519999997)
Ala-Ala-Pro-Pro
C16H26N4O5 (354.19031060000003)
A tetrapeptide composed of two L-alanine units joined to two L-proline units by peptide linkages.
(1S,15R,18S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
C21H26N2O3 (354.19433260000005)
(1S,15R,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
C21H26N2O3 (354.19433260000005)
(-)-Minovincinine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid that is (-)-vincadifformine which carries a hydroxy group at position 19R. A natural product found in several plant species including Catharanthus roseus and Vinca minor.
1-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-pyrazolo[3,4-d]pyrimidinamine
C18H22N6O2 (354.18041519999997)
(1R,15R,18S,19R,20R)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
C21H26N2O3 (354.19433260000005)
[(1R,9R,10S,12R,13S,14R,16S,18R)-13-ethyl-14-hydroxy-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-yl] acetate
C21H26N2O3 (354.19433260000005)
Propyl 2,7,7-trimethyl-5-oxo-4-pyridin-3-yl-3,4,6,8-tetrahydroquinoline-3-carboxylate
C21H26N2O3 (354.19433260000005)
Methyl (2beta,3beta,5alpha,12beta,19alpha)-3-hydroxy-6,7-didehydroaspidospermidine-3-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1S,14S,15S)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1S,11S,17R,18R)-18-[(1R)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
Tert-butyldifluorotris(trimethylsilyl)methylsilane
methyl (1S,9S,12R,16S,18R,21R)-12-oxido-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
(7Z)-7-ethylidene-1-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3-indole]-2-one
C21H26N2O3 (354.19433260000005)
1-lauroyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate having lauroyl (dodecanoyl) as the 1-O-acyl group.
16R,19E-isositsirikine
C21H26N2O3 (354.19433260000005)
A natural product found in Alstonia spatulata.
16-epivincamine
C21H26N2O3 (354.19433260000005)
A natural product found in Alstonia spatulata.
(3R)-3-hydroxy-2,3-dihydrotabersonine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid obtained by formal hydration across the 2,3-double bond of tabersonine.
(+)-Minovincinine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid that is (+)-vincadifformine which carries a hydroxy group at position 19S. A natural product found in several plant species including Alstonia venenata and Catharanthus trichophyllus.
(1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester
C21H26N2O3 (354.19433260000005)
15beta-stemmadenine
C21H26N2O3 (354.19433260000005)
A monoterpenoid indole alkaloid with forumula C21H26N2O3, isolated from the fruits of Tabernaemontana heyneana.
7-chloro-6,9a-dimethyl-6-(4-methylpent-3-en-1-yl)-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-1,9-diol
7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C21H26N2O3 (354.19433260000005)
methyl 15-ethyl-13-(hydroxymethyl)-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2,4,6,8-tetraene-13-carboxylate
C21H26N2O3 (354.19433260000005)
1-{20-hydroxy-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl}ethanone
C21H26N2O3 (354.19433260000005)
(1r,9s,10s,12r,13z,18r)-13-ethylidene-18-(methoxycarbonyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-trien-15-ium-15-olate
C21H26N2O3 (354.19433260000005)
(2s,4s)-5,7-dimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-ol
14-(chloromethyl)-13,14-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
methyl 2-{6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl}prop-2-enoate
C21H26N2O3 (354.19433260000005)
methyl 15-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (16e)-16-ethylidene-2-(hydroxymethyl)-4,14-diazatetracyclo[12.2.2.0³,¹¹.0⁵,¹⁰]octadeca-3(11),5,7,9-tetraene-2-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (13e)-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,14s,15s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
(1s,4s,5r,9s,10r,13s,14s)-14-(chloromethyl)-13,14-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
methyl (1s,11s,17r,18s)-18-[(1r)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,14s,15s,18r)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
(2z)-2-[(5s,7r,9s)-14-hydroxy-9-methoxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl]but-2-enal
C21H26N2O3 (354.19433260000005)
methyl (3r,7r,8s)-7-ethyl-5-methyl-10-oxo-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-3-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,17r,18s)-17-(2-hydroxyethyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
1-[12-(2-hydroxyethylidene)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-8-yl]ethanone
C21H26N2O3 (354.19433260000005)
(1'r,2's,3s,4's,7's,9'r)-1,9'-dimethyl-2'-(2-oxopropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-one
C21H26N2O3 (354.19433260000005)
(2r)-2-{2-[3-(hydroxymethyl)-4-methoxy-2,6-dimethylphenyl]ethyl}-2-methylchromen-6-ol
methyl 2-[(3r,6'r,7'r,8'ar)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]prop-2-enoate
C21H26N2O3 (354.19433260000005)
methyl (2e)-3-methoxy-2-{3-methyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}prop-2-enoate
C21H26N2O3 (354.19433260000005)
7-(1-chloro-2-hydroxyethyl)-2-hydroxy-1,4b,7,10a-tetramethyl-4,4a,5,6,8,8a,9,10-octahydrophenanthren-3-one
methyl 18-(1-methoxyethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
[(1s,9s,10s,11r,12z,17s)-12-(2-hydroxyethylidene)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-10-yl]methyl acetate
C21H26N2O3 (354.19433260000005)
1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methyl-1-oxopent-3-en-2-yl acetate
10-hydroxycoronaridine
C21H26N2O3 (354.19433260000005)
{"Ingredient_id": "HBIN000140","Ingredient_name": "10-hydroxycoronaridine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)O)C(=O)OC","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "14211;14212","PubChem_id": "52948159","DrugBank_id": "NA"}
11-hydroxycoronaridine
C21H26N2O3 (354.19433260000005)
{"Ingredient_id": "HBIN000441","Ingredient_name": "11-hydroxycoronaridine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)O)C(=O)OC","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "15834","PubChem_id": "44566751","DrugBank_id": "NA"}
15α-hydroxykopsinine
C21H26N2O3 (354.19433260000005)
{"Ingredient_id": "HBIN001613","Ingredient_name": "15\u03b1-hydroxykopsinine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "COC(=O)C1CC23CCCN4C2C5(C1(CC3O)NC6=CC=CC=C65)CC4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10292","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
17-chloro-13,16β-dihydroxy-ent-kauran-19-al
{"Ingredient_id": "HBIN002010","Ingredient_name": "17-chloro-13,16\u03b2-dihydroxy-ent-kauran-19-al","Alias": "NA","Ingredient_formula": "C20H31ClO3","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2CCC(C3)(C(C4)(CCl)O)O)C)C=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3548","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
19-heyneanine
C21H26N2O3 (354.19433260000005)
{"Ingredient_id": "HBIN002189","Ingredient_name": "19-heyneanine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36126","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
beta-yohimbine
C21H26N2O3 (354.19433260000005)
{"Ingredient_id": "HBIN018355","Ingredient_name": "beta-yohimbine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6233","PubChem_id": "5458418","DrugBank_id": "NA"}
(11s,12s,17s)-12-[(1s)-1-hydroxyethyl]-10-(methoxycarbonyl)-14-methyl-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-8-ide
C21H26N2O3 (354.19433260000005)
methyl (1s,14s,15r,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,10s,12r,13e,18r)-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
1-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dimethyl-1,2-dihydronaphthalene
methyl (1s,10r,15s,16r,18s)-16-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 17-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 16-(1-hydroxyethyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,11s,17r,18s)-18-ethyl-6-methoxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (13e)-13-ethylidene-9-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,14s,15r,17s,18s)-17-ethyl-14-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
(1'r,3s,4's,7'e,8's,9'r)-7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C21H26N2O3 (354.19433260000005)
methyl 13-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
C21H26N2O3 (354.19433260000005)
(1r,5s,6s,9r,16s)-6-acetyl-16-hydroxy-1,5-dimethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),12(19),14-trien-11-one
methyl (1s,11s,17r,18r)-18-[(1s)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,12s,14s,19r)-14-ethyl-14-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,9s,12s,13e,18r)-13-ethylidene-18-(hydroxymethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 2-{3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
(2s)-1-[(2s)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}propanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid
C16H26N4O5 (354.19031060000003)
(1r,2s)-1-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dimethyl-1,2-dihydronaphthalene
methyl (1r,9r,16r,18r,20r,21r)-20-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (2r)-2-[(2r,3r,12bs)-3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
(1r,9s,10s,12r,13e,15r,18r)-13-ethylidene-18-(methoxycarbonyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-trien-15-ium-15-olate
C21H26N2O3 (354.19433260000005)
(1r,10s)-10-hydroxy-1,6,6-trimethyl-10-(2-oxopropyl)-1h,2h,7h,8h,9h-phenanthro[1,2-b]furan-11-one
(2r)-1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methyl-1-oxopent-3-en-2-yl acetate
(12s,14r,16s,18r)-16-methoxy-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[10.8.1.0²,⁷.0⁸,²¹.0¹⁴,¹⁹]henicosa-2,4,6,8(21),19-pentaen-5-ol
C21H26N2O3 (354.19433260000005)
methyl (1'r,2r,3r,9'r,10's,12'r,18's)-3,8'-dimethyl-8',15'-diazaspiro[oxirane-2,13'-pentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadecane]-2',4',6'-triene-18'-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,11s,17r,18s)-18-[(1s)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,12s,19s)-12-[(1s)-1-hydroxyethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
(3e)-1-{7-formylcyclopenta[c]pyran-4-yl}-4,8-dimethylnona-3,7-dien-2-yl acetate
methyl (1s,9r,12r,19s)-4-methoxy-8,16-diazahexacyclo[10.6.2.0¹,⁹.0²,⁷.0⁹,¹⁹.0¹²,¹⁶]icosa-2,4,6-triene-8-carboxylate
C21H26N2O3 (354.19433260000005)
(1s,9s,16s,18s,21r)-18-(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-trien-12-ium-12-olate
C21H26N2O3 (354.19433260000005)
methyl (1s,2s,11s,12r,16z)-2-ethyl-16-ethylidene-11-(hydroxymethyl)-9,15-diazatetracyclo[10.3.1.0²,¹⁰.0³,⁸]hexadeca-3,5,7,9-tetraene-11-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15s,16r,18s)-16-[(1s)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,12r,14r,15z,18s)-15-ethylidene-12-hydroxy-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
{7-hydroxy-4,8,11-trimethyl-15-methylidene-3-oxotetracyclo[7.6.0.0²,⁶.0¹⁰,¹²]pentadeca-1,6,8-trien-11-yl}methyl acetate
(21s)-11-hydroxy-14-(2-hydroxyethyl)-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6-trien-9-one
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,17s,18s)-17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
1,9'-dimethyl-2'-(2-oxopropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-one
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,18r,19r,20s)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
(2r,4s,5e,6r,8s)-5-ethylidene-4-methoxy-9-methyl-3-oxa-1,9-diazapentacyclo[10.6.1.1²,⁶.0⁸,¹⁹.0¹³,¹⁸]icosa-12(19),13,15,17-tetraen-15-ol
C21H26N2O3 (354.19433260000005)
methyl (1r,9r,15s,16s,18s,21s)-15-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
11-hydroxy-4,9-dimethyl-10-oxa-4,15-diazahexacyclo[10.9.1.0¹,⁵.0⁷,¹².0¹⁵,²².0¹⁶,²¹]docosa-16,18,20-trien-14-one
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,18r,19r,20r)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (13r,15r,17r,19r)-13-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (13e)-13-ethylidene-18-(hydroxymethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (3e)-3-ethylidene-4-{1-[3-(methoxymethyl)-1h-indol-2-yl]ethenyl}piperidine-1-carboxylate
C21H26N2O3 (354.19433260000005)
1-{7-formylcyclopenta[c]pyran-4-yl}-4,8-dimethylnona-3,7-dien-2-yl acetate
methyl (15s,17s,19r)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,12s,19s)-12-ethyl-5-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 12-ethyl-5-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
n-{2-[6-(3,4-dimethoxyphenyl)-7,8-dihydro-5h-quinolin-6-yl]ethyl}-n-methylformamide
C21H26N2O3 (354.19433260000005)
5,7-dimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-ol
(2r,4r,5e,6r,8s)-5-ethylidene-4-methoxy-9-methyl-3-oxa-1,9-diazapentacyclo[10.6.1.1²,⁶.0⁸,¹⁹.0¹³,¹⁸]icosa-12(19),13,15,17-tetraen-15-ol
C21H26N2O3 (354.19433260000005)
methyl (2r)-2-[(2r,3z,12br)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
(2s,3e)-1-{7-formylcyclopenta[c]pyran-4-yl}-4,8-dimethylnona-3,7-dien-2-yl acetate
methyl (1r,12r,19r)-12-[(1r)-1-hydroxyethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 20-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
1-[(1r,4r,12r,16s)-7-hydroxy-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6,8,10-trien-5-yl]ethanone
C21H26N2O3 (354.19433260000005)
methyl (1s,9r,16s,17r,18s,21r)-17-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,14r,15r)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 2-[(3e)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
18-(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-trien-12-ium-12-olate
C21H26N2O3 (354.19433260000005)
methyl 18-ethyl-6-methoxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,12r)-12-(1-hydroxyethyl)-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,10r,12s,13s,14s,15r)-15-ethyl-13-(hydroxymethyl)-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2,4,6,8-tetraene-13-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,14s,15s,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
2-{2-[3-(hydroxymethyl)-4-methoxy-2,6-dimethylphenyl]ethyl}-2-methylchromen-6-ol
methyl (2s)-2-[(2s,3r,12bs)-3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
methyl (1s,14r,15r,17s,18s)-17-ethyl-14-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (2r)-2-[(2s,12bs)-3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
1-[(4s,12s,13r,16r,17s,18r,20r)-20-hydroxy-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl]ethanone
C21H26N2O3 (354.19433260000005)
2-hydroxy-1-[(4r,12s,13r,16s,17s,18r,20s)-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl]ethanone
C21H26N2O3 (354.19433260000005)
2,2',3,3'-tetramethoxy-5,5'-bis(prop-2-en-1-yl)-1,1'-biphenyl
(2r,3r,4s,6r)-6-[(2r,3r,4s,5r,6s)-3,5-dihydroxy-4,6-dimethoxy-2-methyloxan-3-yl]-6-methoxyhexane-2,3,4-triol
methyl (3r,7s,8s)-7-ethyl-5-methyl-10-oxo-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-3-carboxylate
C21H26N2O3 (354.19433260000005)
(4ar,4bs,7s,8as,10as)-7-[(1s)-1-chloro-2-hydroxyethyl]-2-hydroxy-1,4b,7,10a-tetramethyl-4,4a,5,6,8,8a,9,10-octahydrophenanthren-3-one
(1s,2r,4s)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2e,4e)-5-(2h-1,3-benzodioxol-5-yl)penta-2,4-dienoate
methyl 2-{3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
methyl (1r,9r,16s,17r,18s,21r)-17-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
n-{2-[(6s)-6-(3,4-dimethoxyphenyl)-7,8-dihydro-5h-quinolin-6-yl]ethyl}-n-methylformamide
C21H26N2O3 (354.19433260000005)
[(4r,10s,11s,12s)-7-hydroxy-4,8,11-trimethyl-15-methylidene-3-oxotetracyclo[7.6.0.0²,⁶.0¹⁰,¹²]pentadeca-1,6,8-trien-11-yl]methyl acetate
methyl 3,8'-dimethyl-8',15'-diazaspiro[oxirane-2,13'-pentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadecane]-2',4',6'-triene-18'-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 15-ethylidene-12-hydroxy-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,12r,19r)-12-(1-hydroxyethyl)-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (13r,15r,17s,19r)-13-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
C21H26N2O3 (354.19433260000005)
(1r,5ar,6s,7s,9s,9as,9bs)-7-chloro-6,9a-dimethyl-6-(4-methylpent-3-en-1-yl)-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-1,9-diol
(1s,4r,5r,9s,10s,13s,14s)-14-(chloromethyl)-13,14-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
methyl (1r,15s,17r,18r)-17-[(1s)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,11s,17r,18r)-18-ethyl-6-methoxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (15z)-15-ethylidene-12-hydroxy-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15s,18r,19r,20r)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,17r,18s)-17-[(1s)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
(1s,9s,12s,16s,18s,21r)-18-(methoxycarbonyl)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-trien-12-ium-12-olate
C21H26N2O3 (354.19433260000005)
(1'r,3s,4's,7'e,8'r,9's)-7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C21H26N2O3 (354.19433260000005)
methyl (1s,15s,17s,18s)-17-ethyl-7-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 17-ethyl-14-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (2r)-2-[(2r,3z,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
methyl 16-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,15s,18s,19s,20r)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (2r)-2-[(2s,3r,12bs)-3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
methyl (1s,12r,14r,15e,18s)-15-ethylidene-12-hydroxy-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,15s,18s,19s,20s)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
1-[(1r,9s,10s,11r,12z,17s)-12-(2-hydroxyethylidene)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-8-yl]ethanone
C21H26N2O3 (354.19433260000005)
2-hydroxy-1-{16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl}ethanone
C21H26N2O3 (354.19433260000005)
(2e)-2-[(5s,7r,9s)-14-hydroxy-9-methoxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl]but-2-enal
C21H26N2O3 (354.19433260000005)
methyl (1s,10r,15s,17s,18s)-17-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,10r,12s,13r,14s,15r)-15-ethyl-13-(hydroxymethyl)-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2,4,6,8-tetraene-13-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,9r,16s,18r,21r)-15-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
6-acetyl-16-hydroxy-1,5-dimethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),12(19),14-trien-11-one
methyl 2-[(1r,9r,16s,19s)-5-methoxy-2,12-diazapentacyclo[10.6.1.0¹,⁹.0³,⁸.0¹⁶,¹⁹]nonadeca-3,5,7,14-tetraen-16-yl]acetate
C21H26N2O3 (354.19433260000005)
(7'z)-7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,17r,18s)-17-ethyl-16-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15s,17s,18s)-17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
13-hydroxy-6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3,5,7,10,14-hexaen-9-one
methyl (1r,15r,18r,19r,20s)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (2s)-2-[(2r,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C21H26N2O3 (354.19433260000005)
methyl 15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 9'-ethyl-3-oxo-1h-7'-azaspiro[indole-2,4'-tricyclo[5.3.1.0³,⁸]undecane]-3'-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (15r,17s,19s)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,12s,14r,19r)-14-ethyl-14-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
(1'r,3s,4's,7'z,8'r,9's)-7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C21H26N2O3 (354.19433260000005)
(1'r,2's,3r,4's,7's,9'r)-1,9'-dimethyl-2'-(2-oxopropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-one
C21H26N2O3 (354.19433260000005)
(11s,12s,17s)-12-[(1r)-1-hydroxyethyl]-10-(methoxycarbonyl)-14-methyl-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-8-ide
C21H26N2O3 (354.19433260000005)
methyl (1s,10r,15r,17s,18s)-17-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2,4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,15r,20s)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C21H26N2O3 (354.19433260000005)
6-(3,5-dihydroxy-4,6-dimethoxy-2-methyloxan-3-yl)-6-methoxyhexane-2,3,4-triol
4-(4-{3-methoxy-8,13-dioxatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-trien-9-yl}butyl)phenol
methyl (1r,14r,15r,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
13-ethylidene-18-(methoxycarbonyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-trien-15-ium-15-olate
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,17s,18s)-17-[(1r)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
(13s)-13-hydroxy-6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3,5,7,10,14-hexaen-9-one
methyl (1s,2s,16z)-16-ethylidene-2-(hydroxymethyl)-4,14-diazatetracyclo[12.2.2.0³,¹¹.0⁵,¹⁰]octadeca-3(11),5,7,9-tetraene-2-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 12-(1-hydroxypropan-2-yl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1r,12s,13r,19r)-12-ethyl-13-hydroxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C21H26N2O3 (354.19433260000005)
(1r,4r,12r,16s)-7-methoxy-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9-triene-5-carbaldehyde
C21H26N2O3 (354.19433260000005)
methyl (1r,9s,10s,12r,13e,18s)-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
7-methoxy-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-6(11),7,9-triene-5-carbaldehyde
C21H26N2O3 (354.19433260000005)
[(1s,9s,10s,11r,17s)-12-(2-hydroxyethylidene)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-10-yl]methyl acetate
C21H26N2O3 (354.19433260000005)
2-hydroxy-1-[(4r,12s,13r,16r,17s,18r,20s)-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl]ethanone
C21H26N2O3 (354.19433260000005)
methyl (1s,12r,14s,15e,18s)-15-ethylidene-12-hydroxy-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl 17-(1-hydroxyethyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,9s,11s,12e,18s)-12-ethylidene-18-(hydroxymethyl)-8,15-diazapentacyclo[9.6.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (16z)-2-ethyl-16-ethylidene-11-(hydroxymethyl)-9,15-diazatetracyclo[10.3.1.0²,¹⁰.0³,⁸]hexadeca-3,5,7,9-tetraene-11-carboxylate
C21H26N2O3 (354.19433260000005)
methyl (1s,15r,17r,18s)-17-[(1r)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C21H26N2O3 (354.19433260000005)